Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy

References

• Albrecht H, Hoffmann C, Degen O, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998; 12: 1149–1154
   PubMed Web of Science ®Google Scholar
• Andrei G, Snoeck R, van Deputte M, de Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemoth 1997; 41: 587–593
   PubMed Web of Science ®Google Scholar
• Antinori A, Ammassari A, De Luca A, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combination with polymerase chain reaction assays in CSF. Neurology 1997; 48: 687–694
   PubMed Web of Science ®Google Scholar
• Autran B, Garcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112–116
   PubMed Web of Science ®Google Scholar
• Baqi M, Kucharczyk W, Walmsley SI. Regression of progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 1997; 11: 1526–1527
   PubMed Web of Science ®Google Scholar
• Berger JR, Kaszovitz B, Post JD, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literaure with a report of sixteen cases. Ann Int Med 1987; 107: 78–87
   PubMed Web of Science ®Google Scholar
• Berger JR, Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirol 1995; 1: 5–18
   PubMed Web of Science ®Google Scholar
• Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998a; 4: 59–68
   PubMed Web of Science ®Google Scholar
• Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 1998b; 44: 341–349
   PubMed Web of Science ®Google Scholar
• Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Climes 1984; 2: 299–313
   PubMed Web of Science ®Google Scholar
• Brosgard C, Roberts T, Safrin S, Marra CM, Colson N, Jaffre HS. Cidofovir therapy for progressive multifocal leukoencephalopathy in two AIDS patients (abstract). 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. TorontoCanada 1997
   Google Scholar
• Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by polymerase chain reaction. AIDS 1997; 11: 1–17
   PubMed Web of Science ®Google Scholar
• Cinque P, Casari S, Bertelli D. Progressive multifocal leukoencephalopathy, HIV and highly active antiretroviral therapy. New Engl J Med 1998; 339: 838–849
   Google Scholar
• Clifford D. Neurologic AIDS Research Consortium and Natural history of progressive multifocal leukoencephalopathy (PML) in AIDS modified by antiretroviral therapy. J Neurovirol 1998; 4: 346
   Google Scholar
• Domingo P, Guardiola JM, Iranzo A, Margall N. Remission of progressive multifocal leukoencephalopathy after antiretroviral therapy. Lancet 1997; 349: 1554–1555
   PubMedGoogle Scholar
• Elliott B, Aromin I, Gold R, Flanigan T, Mileno M. 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Lancet 1997; 349: 850
   Google Scholar
• Fong IW, Toma E. The natural history of progressive multifocal leukoencephalopathy. Clin Infect Dis 1995a; 20: 1305–1310, the Canadian PML study group
   PubMed Web of Science ®Google Scholar
• Fong IW, Britton CV, Luinstra KK, Toma E, Mahony JB. Diagnostic value of detecting virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 1995b; 33: 484–486
   PubMed Web of Science ®Google Scholar
• Gibson PE, Knowles WA, Hand JF, Brown DWG. Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Med Virol 1993; 39: 278–281
   PubMed Web of Science ®Google Scholar
• Gillepsie SM, Chang Y, Lemp G, et al. Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco 1981-1989. Ann Neurol 1991; 30: 597–604
   Google Scholar
• Hall CD, Dafni U, Simpson D. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Eng J Med 1998a; 338: 1345–1351, the AIDS Clinical Trial Group 343 Team
   PubMed Web of Science ®Google Scholar
• Hall CD, Yiannoutsos C, Clifford DB. Progressive multifocal leukoencephalopathy, HIV and highly active antiretroviral therapy. Reply. New Engl J Med 1998b; 339: 848–849
   Google Scholar
• Holman RC, Janseen RS, Buehler JW, Zelasky MT, Hooper WC. Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance. Neurology 1991; 41: 1733–1736
   PubMed Web of Science ®Google Scholar
• Hou J, Major EO. The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol 1998; 4: 451–456
   PubMed Web of Science ®Google Scholar
• Huang SS, Skolasky GJ, Dal Pan Royal W, McArthur JC. Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-Interferon: an observational study. J Neurovirol 1998; 4: 324–332
   PubMed Web of Science ®Google Scholar
• Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J. Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 1985; 17: 344–349
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452
   PubMed Web of Science ®Google Scholar
• Major EO, Ault GS. Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficiency patient. Curr Opin Neurol 1995; 8: 184–190
   Google Scholar
• Matheron S, Girard PM, Duval X, Petitdidier C, Bortolotti V, Gasnault J. Evaluation of cidofovir for progressive multifocal leukoencephalopathy (abstract). 5th Conference on Retroviruses and Opportunistic Infection. ChicagoUSA 1998
   Google Scholar
• McGuire D, Barhite S, Hollander H, Miles M. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 1995; 37: 395–399
   PubMed Web of Science ®Google Scholar
• Miller J, Barrett R, Britton C. Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. New Engl J Med 1982; 307: 1436–1438
   PubMed Web of Science ®Google Scholar
• Moret H, Guichard M, Matheron S, et al. Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol 1993; 31: 3310–3313
   PubMed Web of Science ®Google Scholar
• Power C, Nath A, Aoki FY, Del Bigio M. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N Engl J Med 1997; 336: 661–662
   PubMed Web of Science ®Google Scholar
• Sadler M, Chinn R, Healy J, Fisher M, Nelson MR, Gazzard BG. New treatments for progressive multifocal leukoencephalopathy in HIV-1 infected patients. AIDS 1998; 12: 533–535
   PubMedGoogle Scholar
• Taoufik Y, Froger D, Benoliel S, et al. Quantitative Elisa-polymerase chain reaction at saturation using homologous internal DNA standards and chemiluminescence revelation. Eur Cytokine Network 1998a; 9: 197–204
   Google Scholar
• Taoufik Y, Gasnault J, Karaterki A, et al. Prognostic value of JC Virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Infect Dis 1998b; 178: 1816–1820
   PubMed Web of Science ®Google Scholar
• Von Einsiedel RW, Fife TD, Aksamit AJ, et al. Progressive multifocal leukoencephalopathy in AIDS: a clinicopathological study and review of the literature. J Neurol 1993; 240: 391–406
   PubMed Web of Science ®Google Scholar
• Weber T, Turner RW, Frye S, et al. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 1994; 169: 1138–1141
   PubMed Web of Science ®Google Scholar
• Weber T, Frye S, Bodemer M, Otto M, Luke W. Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system. J Neurovirol 1996; 2: 175–190
   Web of Science ®Google Scholar